DrugPatentWatch Database Preview
Teikoku Pharma Company Profile
» See Plans and Pricing
What is the competitive landscape for TEIKOKU PHARMA, and when can generic versions of TEIKOKU PHARMA drugs launch?
TEIKOKU PHARMA has two approved drugs.
There are three US patents protecting TEIKOKU PHARMA drugs.
There are twenty-four patent family members on TEIKOKU PHARMA drugs in nineteen countries and three supplementary protection certificates in three countries.
Summary for Teikoku Pharma
| International Patents: | 24 |
| US Patents: | 3 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Teikoku Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teikoku Pharma | DOCETAXEL | docetaxel | INJECTABLE;INJECTION | 205934-002 | Dec 22, 2015 | AP | RX | No | No | 9,308,195 | Start Trial | Y | Start Trial | ||
| Teikoku Pharma | DOCETAXEL | docetaxel | INJECTABLE;INJECTION | 205934-003 | Dec 22, 2015 | AP | RX | No | No | 8,940,786 | Start Trial | Y | Start Trial | ||
| Teikoku Pharma | DOCETAXEL | docetaxel | INJECTABLE;INJECTION | 205934-001 | Dec 22, 2015 | AP | RX | No | No | 8,940,786 | Start Trial | Y | Start Trial | ||
| Teikoku Pharma | DOCETAXEL | docetaxel | INJECTABLE;INJECTION | 205934-003 | Dec 22, 2015 | AP | RX | No | No | 9,308,195 | Start Trial | Y | Start Trial | ||
| Teikoku Pharma | DOCETAXEL | docetaxel | INJECTABLE;INJECTION | 205934-002 | Dec 22, 2015 | AP | RX | No | No | 9,763,880 | Start Trial | Start Trial | |||
| Teikoku Pharma | DOCETAXEL | docetaxel | INJECTABLE;INJECTION | 205934-001 | Dec 22, 2015 | AP | RX | No | No | 9,308,195 | Start Trial | Y | Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Teikoku Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Teikoku Pharma Usa | LIDODERM | lidocaine | PATCH;TOPICAL | 020612-001 | Mar 19, 1999 | 5,411,738 | Start Trial |
| Teikoku Pharma Usa | LIDODERM | lidocaine | PATCH;TOPICAL | 020612-001 | Mar 19, 1999 | 5,827,529 | Start Trial |
| Teikoku Pharma Usa | LIDODERM | lidocaine | PATCH;TOPICAL | 020612-001 | Mar 19, 1999 | 5,709,869 | Start Trial |
| Teikoku Pharma Usa | LIDODERM | lidocaine | PATCH;TOPICAL | 020612-001 | Mar 19, 1999 | 5,741,510 | Start Trial |
| Teikoku Pharma Usa | LIDODERM | lidocaine | PATCH;TOPICAL | 020612-001 | Mar 19, 1999 | 5,441,738 | Start Trial |
| Teikoku Pharma Usa | LIDODERM | lidocaine | PATCH;TOPICAL | 020612-001 | Mar 19, 1999 | 5,589,180 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for TEIKOKU PHARMA drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Topical Patch | 5% | ➤ Subscribe | 2009-11-13 |
International Patents for Teikoku Pharma Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Brazil | 112015006692 | Start Trial |
| Japan | 2015534558 | Start Trial |
| Argentina | 092759 | Start Trial |
| Mexico | 2015003824 | Start Trial |
| South Korea | 102165394 | Start Trial |
| Hong Kong | 1259184 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Teikoku Pharma Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0253738 | C960002 | Netherlands | Start Trial | PRODUCT NAME: DOCETAXEL, DESGEWENST IN DE VORM VAN EEN TRIHYDRAAT; REGISTRATION NO/DATE: EU/1/95/002/001 - EU/1/95/002/002 19951127 |
| 1667986 | 92172 | Luxembourg | Start Trial | PRODUCT NAME: SOLVAT ACETONIQUE DU CABAZITAXEL, OU DESIGNE SOLVAT ACETONIQUE DU DIMETHOXY DOCETAXEL OU SOLVAT ACETONIQUE DU (2R,3S)-3-TERT-BUTOXYCARBONYLAMINO-2-HYDROXY-3-PHENYLPROPIONATE DE 4-ACETOXY-2A-BENZOYLOXY-5BETA,20-EPOXY-1-HYDROXY-7BETA,10A-DIMETHOXY-9-OXO-TAX-11-ENE-13A-YLE(ACETONATE DU CABAZITAXEL) |
| 1667986 | 28/2013 | Austria | Start Trial | PRODUCT NAME: DIMETHOXYDOCETAXEL-ACETONSOLVAT (CABAZITAXEL-ACETONSOLVAT); REGISTRATION NO/DATE: EU/1/11/676/001 20110317 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
